iSpecimen Inc. (NASDAQ:ISPC – Get Free Report) rose 1.5% on Thursday . The stock traded as high as $2.19 and last traded at $2.08. Approximately 159,700 shares were traded during trading, a decline of 82% from the average daily volume of 898,239 shares. The stock had previously closed at $2.05.
iSpecimen Price Performance
The firm has a market cap of $2.04 million, a PE ratio of -0.11 and a beta of 1.63. The business has a fifty day moving average price of $2.83 and a two-hundred day moving average price of $2.83.
iSpecimen (NASDAQ:ISPC – Get Free Report) last released its earnings results on Thursday, November 7th. The company reported ($2.10) earnings per share for the quarter. The business had revenue of $2.66 million for the quarter. iSpecimen had a negative net margin of 91.66% and a negative return on equity of 139.25%.
About iSpecimen
iSpecimen Inc provides technology that connects life science researchers who need human biofluids, tissues, and living cells for their research with biospecimens available in healthcare provider organizations worldwide. Its cloud-based technology enables scientists to search for specimens and patients across a network of hospitals, clinics, private practice groups, laboratories, blood centers, biobanks, clinical research sites, and cadaveric donation centers.
See Also
- Five stocks we like better than iSpecimen
- Stock Dividend Cuts Happen Are You Ready?
- Chipotle’s Slip: A Short-Term Dip or Long-Term Opportunity?
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- Why New Tariffs Could Boost These 3 Basic Materials Stocks
- High Flyers: 3 Natural Gas Stocks for March 2022
- MarketBeat Week in Review – 02/03 – 02/07
Receive News & Ratings for iSpecimen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iSpecimen and related companies with MarketBeat.com's FREE daily email newsletter.
